9月14日 - ** 强生公司（JNJ.N）股价在盘前交易中上涨1.3%，报268.96美元
** 据彭博社周五援引消息人士报道，阿波罗全球管理公司（APO.N）正就收购该公司骨科业务部门进行谈判（(link)），该交易估值可能接近200亿美元
** 报道称，双方可能在数周内达成协议
** 该部门2025年营收达93亿美元，但因髋关节置换装置问题面临数千起诉讼
** 在26家券商中，有19家对该股给出“买入”或更高评级，7家给出“持有”评级；其目标价中位数为282美元——伦敦证券交易所集团（LSEG）汇编的数据
** 截至昨日收盘，该股今年以来累计上涨28.3%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.